Company overview
Emulate provides Organ-on-a-Chip technology, including the Human Emulation System and AVA Emulation System, to model human organ functions like liver, kidney, and intestine for drug development and toxicology testing. These microfluidic platforms replicate human tissue responses more accurately than animal models, reducing R&D costs and translational failures. The company serves pharmaceutical, academic, and government researchers with validated chips for applications in cancer, immunology, and infectious diseases.
Emulate is listed in the NovaPharmaNews Supplier Hub as a CRO & Clinical Services partner serving United States & Americas. Core focus areas include organ-on-a-chip, emulate, human emulation system, drug toxicity testing, microphysiological systems.
Industry categories: CRO & Clinical Services. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Emulate include Cro — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://emulatebio.com
- Categories
- CRO & Clinical Services
- Markets served
- United States & Americas
- Keywords
- organ-on-a-chip, emulate, human emulation system, drug toxicity testing, microphysiological systems
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What Organ-Chip models does Emulate offer?
- Emulate offers Liver-Chip, Colon Intestine-Chip, Duodenum Intestine-Chip, Kidney-Chip, and consumables like Chip-S1 (stretchable), Chip-R1 (rigid for ADME/toxicology), and Chip-A1 (accessible for 3D tissue modeling).
- Is Emulate's technology validated for regulatory use?
- Emulate's Organ-Chips are supported by over 100 peer-reviewed papers, FDA fast-tracking, and collaborations with pharma giants like Pfizer and J&J; liver chips detect drug toxicity early, with NASA validation in microgravity.
- What geographies does Emulate serve?
- Emulate operates globally, serving pharmaceutical companies, academia, government, and industries in the US and internationally, with partnerships including Pfizer, J&J, and research in cancer, Alzheimer's, and rare diseases.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
